At The Royal Society Discussion Meeting, Origins of HIV and the AIDS epidemic, which this issue records, Edward Hooper added two new`smoking guns' to the accusations published previously in The river. These were proposed as conclusive evidence for the hypothesis that simian immunode¢ciency viruscontaminated CHAT polio vaccine caused the HIV-1 group M epidemic. We have investigated the facts in relation to these`smoking guns'.
The ¢rst of the`smoking guns' was a statement made by Louis Bugyaki, a veterinarian who is now 80 years old, and who worked previously at the veterinary laboratory at Stanleyville. He acted as a consultant with regard to the feeding problems of the chimps at Camp Lindi, as the caretakers had substantial di¤culties in ¢nding a diet the animals would accept. Although in a previous written statement, quoted in the previous article (Plotkin, this issue; Bugyaki 2000a) he had denied any knowledge of chimpanzee tissues being sent out of the Belgian Congo, Bugyaki (2000b) signed the following statement for Hooper.
Two of the p hysicians who worked at Lindi (Gaston Ninane and Paul Osterrieth) told me that chimpanzee organs, kidneys for the most part, were sent from Stanleyville to the United States, at the request of Dr Koprowski. It is possible that the dispatch of kidneys had for objective to furnish cells in which the polio vaccines of Dr Koprowski could be cultivated. The Belgian p hysicians mentioned above told me that the dispatch of chimpanzee kidneys outside of the country should remain secret. I think that there was a strong possibility that it was a commercial secret and that the producers of the vaccine did not want that their competitors, such as Albert Sabin and Jonas Salk, learn the role played by the chimpanzees in the production of the vaccine.
Bugyaki was concerned about quotations in the press after the London meeting and asked to meet with us. He signed a new statement in the presence of two witnesses at the Institut Scienti¢que de Sante¨Publique in Brussels. In this additional statement, Bugyaki denies that he was told about chimpanzee organ shipments by Ninane or Osterrieth, and complains about being misquoted. He insisted that his information came from a laboratory assistant at Lindi in a conversation held many years after the events.
The newest statement by Bugyaki (2000c) reads, in part, as follows:
I remember very well having said to these journalists on several occasions that I was not resp onsible for the camp at Lindi and that I did not work at the Provincial Medical Laboratory at Stanleyville. The information quoted on the subject of chimpanzees came to me from a laboratory assistant, a sanitary agent, who worked at the Provincial Laboratory, and not from the physicians themselves. The articles do not quote me correctly.
That person told me the story on the occasion of a meeting in Belgium, a long time after our return from the Congo. I indicated to the journalists that only Drs P. Osterrieth and G. Ninane could furnish them with ¢rst hand information . . . .
In fact, the two ¢rst-hand witnesses identi¢ed by Bugyaki gave opposite testimony. Before his death in July 2000, Ninane had denied sending chimp kidneys abroad, and Paul Osterrieth has repeated his prior denial (see Plotkin, this issue).
Chimpanzee kidneys were never sent to the Wistar Institute, only to Dr Deinhardt at his demand. Dr Koprowski had nothing to do with it. If Dr Bugyaki really told Mr Hooper what he says he did, I really wonder how and where he got these incredible ideas, certainly not from me (Osterrieth 2000) .
In addition, we ascertained that the sanitary agent mentioned by Bugyaki was Jean Brakel, deceased in May 1994 , who had worked with G. Courtois at the Provincial Medical Laboratory, and who helped at Camp Lindi with regard to the polio and hepatitis experiments. We contacted his widow, who wrote to us as follows:
My husbandperformed the surgicalprocedure for recovering the spinal cord from anesthetized chimpanzees. To my knowledge, no other organs were removed from the corpses (Brakel 2000) .
In conclusion, taking into account his two statements to us, the ¢rst written in his own hand, the best that can be said is that although Bugyaki's memory of the events is confused, his testimony is in any case about hearsay, not about things he actually witnessed. In the statement taken by Hooper he speculates about the purpose for which chimpanzee tissues were used and about why the subject should have been kept secret. At no point does he recount events to which he was eyewitness. The fact remains that the only factual evidence for transport of chimp kidneys out of the Congo is the shipments made to Fritz Deinhardt (Deinhardt et al. 1962) .
THE SUPPOSED CHIMPANZEES OF BUJUMBURA (EARLIER USUMBURA), BURUNDI
The second`smoking gun' of Hooper is the allegation that chimpanzees were caged at Bujumbura, that they were subjected to unilateral nephrectomies, and the kidneys shipped to Butare, Elisabethville or Stanleyville for local production of CHAT polio vaccine. These animals are said to have been received from a primate centre of the Institut pour la Recherche Scienti¢que en Afrique Central (IRSAC) at a place called Kabonambo, supposedly in the Ruzizi Valley. The evidence o¡ered is testimony from a former African worker (called Juma Jamnabas) at the Medical Laboratory of Bujumbura, allegedly corroborated with respect to nephrectomies on chimps by the testimony of another African worker at Camp Lindi (called Antoine).
However, the records of the Medical, Veterinary and Public Health Laboratories at Bujumbura for the period 1957^1960 in the African Archives in Brussels do not con¢rm the presence of chimpanzees in Bujumbura, nor is there con¢rmation of the existence of a holding centre at Kabonambo (African Archives 1953^1959; 1956^1960) .
In addition, we contacted several persons who worked in Bujumbura. J. Yanssen was a sanitary agent at the Medical Laboratory from 1957 to 1961. He continued to serve the newly installed Burundese government as technical advisor until 1974. His statement is as follows:
On October 25, 2000, I was visited by Mme S Horel [a French journalist] and Mr E. Hoop er, under the pretext that she wished to write an article on the quality of the medical services of the former Belgian Congo. . . . To a question concerning which animals there were at Usumbura when I arrived, I replied that there only toads, guinea p igs and later rabbits. To a question about whether there were cages for chimpanzees behind the laboratory buildings, I gave a con¢-dent denial in complete con¢dence. Neither at my arrival, nor after the extension of the buildings. In view of their resistance, I strongly emphasized the fact they were following a false trail, even more concerning the dispatch of chimpanzee tissues to Astrida. I remember having comp ared their investigations to the periodic search for the Loch Ness monster.
I also insisted on the fact that the personality of Dr F. Dierckx did not ¢t in any way with the p ractice of operations on chimpanzees. A clinician and humanist philosop her, he would never have accepted such practices. Moreover, he didn't disp ose of the space to do such, and he could not have done it without my knowledge' (Yanssen 2000) .
In addition, H. Meyus, who was in charge of the Public Health Service at Bujumbura during 1952 to 1959, states that there were no chimpanzees in the Bujumbura laboratories and no surgery performed there.
From September 1952 till February 1959, I exercised the function of medical doctor-hygienist and of Director of the Hygiene Service (of Ruanda-Urundi). Never have there existed annex buildings, for chimpanzees or other ap e species, in the Hygiene Service in Usumbura. Since there were no ape species, obviously, there has never been conducted a hemi-nephrectomy and hence not any type of organ shipment.
To summarize: (1) there were no annex buildings, not for chimpanzees, nor for any other animal sp ecies; (2) a heminephrectomy was never done because there were no animals; (3) neither was there any shipment of animal organs, of any species (Meyus 2000) .
The testimony of F. Lechanteur, who headed the Medical Laboratory at Bujumbura from May 1957 to March 1958 and also from April 1959 to March 1960, is also pertinent. From March 1958 to March 1959 he directed the Medical Laboratory at Astrida. Thus, he was in a perfect position to know whether chimpanzees or their tissues were available. He con¢rms that there were no cages for chimpanzees at the Bujumbura Medical Laboratory, and that no chimpanzee organs were received at Astrida (Lechanteur 2000) .
As a consequence, there is absolutely no documentary evidence or con¢rmation by Belgian sta¡ that chimpanzees were ever housed at Bujumbura.
SHIPMENT OF KIDNEYS TO BUTARE, RWANDA
Hooper's`smoking gun' story postulates that the kidneys supposedly removed at Bujumbura were sent to the Veterinary Laboratory at Butare (Queen Astrida Institute) and/or to Elisabethville, where they were supposedly placed in culture for the manufacture of polio vaccine.
We have examined the records of the Veterinary Laboratory at Butare, and ¢nd mention of veterinary and human vaccine manufacture, including BCG, smallpox and rabies, but no reference to p olio vaccine or to the use of chimpanzee kidneys (African Archives 1947^1955; 1957^1959).
Here we have the ¢rst-hand testimony of Constant Huygelen, a veterinarian who testi¢ed that he came to the Astrida Institute in late 1957 and that he set up the ¢rst tissue culture laboratory there only in 1959, which is con¢rmed in the 1959 annual report of the institution (African Archives 1957^1959). He clearly states that no chimpanzee kidneys were ever received and that no polio vaccine was ever made in Butare.
I worked in the Veterinary Laboratory of Butare (then called Astrida) from end 1957 until October 1960. When I arrived at the laboratory there was no virological work being done except in animals and the diagnosis of some diseases like rabies. The only work related to human medicine consisted of (1) the production of smallp ox vaccine for humans use by scari¢cation of the skin of heifers and inoculating them with vaccinia virus and (2) the production of Fermi-type vaccine use by intracerebral inoculation of sheep and harvesting their brains a week later (Huygelen 2000a ).
In addition, G. Van den Abbeele, head of the Astrida Medical Laboratory, states categorically that no chimpanzee kidneys were used there.
To my knowledge there were no chimpanzees kept at the Ujumbura Medical Laboratory. During the Astrida period, we did not use primary cell cultures. There were no chimpanzees in the animal house. We never received organs from Ujumbura (Van den Abbeele 2000).
There is also the witness of H. Vanderborght, who came to Astrida in 1967 to head the IRSAC laboratory, and who did not see or hear of any preceding housing of chimps in Butare (Vanderborght 2000) .
During his talk at The Royal Society, Hooper stated that the chimps operated on in Bujumbura came from and were sent back to a holding station in Kabonambo, in the Congo, which he says was also headquarters for the Ruzizi vaccination with CHAT polio vaccine. However, Kabonambo is in Burundi, and no record exists of chimps having been kept there. Another witness, U. Rahm, came with her husband to the Congo in mid-1958 in order for him to take up his position as director of the Mammalogy Department at IRSAC in Lwiro. She has no knowledge of chimpanzees being kept in the Ruzizi or in a place called Kabonambo (Rahm 2000) .
ELISABETHVILLE
The other veterinary laboratory postulated by Hooper to have manufactured polio vaccine was at Elisabethville, where veterinarian Tadeusz Wiktor is speci¢cally named as the person who produced the vaccine.
However, the archives of the Elisabethville Veterinary Laboratory for 1957^1960 make no mention of work on polio vaccine (African Archives 1954^1958a,b) .
A key witness to events at Elisabethville is S. Pattyn, a virologist who worked at the nearby Bacteriological Laboratory. He would have had knowledge of local production of polio vaccine, but his statement below is quite clear in its denial.
I can con¢rm that between 1955 and 1960 no tissue cultures were done in the veterinary laboratory at Elisabethville (Lubumbashi) and that certainly p oliovaccine was never produced there nor elsewhere in that city during that p eriod (Pattyn 2000) .
We also interviewed three Belgian veterinarians who worked with Dr Wiktor at Elisabethville before, during and after the critical 1957^59 period. Their signed statements are unanimous in denying that Wiktor ever prepared a polio vaccine (Bouillet 2001; Fasseaux 2001; Thils 2001) .
With regard to the alleged production of polio vaccine by Wiktor, neither his personnel ¢le nor his publications reveal any interest in poliovirus (African Archives 19531 960). One of us (S.A.P.) knew Tad Wiktor quite well later on at the Wistar Institute where we collaborated on rabies vaccine development, but never did he say anything about having produced polio vaccine. The impression that he never did so is strengthened by the recollections of his wife, Hanka (H. Wiktor, personal communication, 5 October 2000). In addition, Martin Kaplan, formerly of the World Health Organization, visited Wiktor's laboratory in Elisabethville, and remembers that Tad never mentioned to me that he worked on tissue cultures before he came to Wistar. I visited his lab in Elisabethville. As far as I know he never worked on p olio and never mentioned chimp cell cultures (Kap lan 2000).
Huygelen and Mortelmans, who were also familiar with the Elisabethville Veterinary Laboratory, con¢rm that Tad Wiktor had not worked on polio (Huygelen 2000b ; J. Mortelmans, personal communication to J.D., 2 November 2000). The inevitable conclusion from the above is that there is a total absence of evidence that chimpanzee kidneys arrived at the two veterinary institutes or that CHATvaccine was ever produced at those places.
INSTITUT POUR LA RECHERCHE SCIENTIFIQUE EN AFRIQUE CENTRAL (IRSAC) AT LWIRO (KIVU, CONGO)
In the course of our investigation, a possible although partial explanation of the discrepancy between Hooper's evidence and that given above emerged. We learned that in 1964, at the Lwiro IRSAC facility, surgery with removal of one kidney was done on a single chimpanzee. This kidney was used to produce cell culture for virological research on infectious hepatitis. The context was a joint project between the Delta Regional Primate Research Center in Louisiana and the IRSAC on several aspects of human infectious hepatitis (IRSAC 1960^1964). William D. Hillis, then at the Delta Laboratory, now at Baylor University, was the physician who removed a single kidney from one chimpanzee and processed it for cell cultures. The objective was to study endogenous viruses of chimpanzees and to attempt to cultivate hepatitis viruses in chimpanzee cells. Hillis (2000) states as follows:
The objective of this work was to make a primary kidney cell culture, to infect the culture with an inoculum susp ected to contain hepatitis virus and in future to infect the same chimpanzee and to examine the clinical and laboratory ¢ndings.
Hillis adds:
I have no p ersonal knowledge of other nephrectomies in Africa, nor of any chimpanzee work in Rwanda or Burundi.
The experiment was prematurely terminated in August 1964 owing to a local rebellion, which caused the IRSAC sta¡ to £ee the country. The cell cultures were never inoculated and soon p erished.
The chimpanzee operated on by Hillis was caught by Ursula Rahm (Rahm 1967) . Chimpanzee capture was performed in the north-eastern Congo, and care was taken to keep the animals alive while they were transported to the Lwiro facility (Rahm 2000) .
These events may or may not explain the memories of some Africans collected by Hooper, but they have no bearing on CHAT virus or the introduction of HIV-1 into humans.
H. GELFAND
Hooper also contended at The Royal Society meeting that Henry Gelfand, an epidemiologist from Tulane University who had worked on the CHAT vaccination project, held views on the vaccine lots distributed in the Congo di¡erent from our own. Speci¢cally, Gelfand is Postscript S. A. Plotkin and others 827 quoted by Hooper as saying that the frozen vaccine he picked up in Brussels in August 1958 had been manufactured in Belgium, and that Gelfand thought he had delivered it to Le¨opoldville, Stanleyville, Bukavu and Elisabethville.
However, Dr Gelfand himself subsequently wrote us the following letter. 1 First, let me state for the record that Mr Hoop er . . . indicated only that he was writing a book to document the vaccination campaign in Congo, and made no mention of AIDS. This is imp ortant because I considered that the source of the vaccine was not crucial to my part of the story (and would be learned from Wistar Institute p ersonnel or records), and I was therefore willing to sp eculate in answer to questions he put to me and to agree with the p ossibility of suggestions he made. I repeatedly told him that my memory was hazy and unreliable. Now for some sp eci¢c points:
1. I believe that I did not carry vaccine from the United States, but rather p icked it up in Brussels. I seem to recall asking Ghislain Courtois if the Public Health Institute in Brussels was manufacturing vaccine, and he said,`No'. Mr Hoop er brought up the p ossibility of Rega Institute or RIT [Recherches et Industries The¨rapeu-tiques] as manufacturing sources, and I said that I have no knowledge of them; he did not suggest the p ossibility of Brussels as a dep ot for Wistar-made vaccine, and I did not think of it. Thus, another laboratory in Belgium remained the speculation. At this time (in the year 2000) I cannot, from personal knowledge, say where the vaccine was made. 2. It is not correct to say,`Dr Gelfand is unsure, but he believes that he also carried the vaccine onwards to Stanleyville, Bukavu, and Elizabethville' . What is correct is that (as I told Mr Hoop er) I am unsure but it is very unlikely that I carried vaccine from Leo to other cities in Congo. My mission was to work with the public health p eople in Leo and then to relay information about that campaign, and vaccine dilution and use, to authorities in other cities. 3. I sp oke again with Mr Hooper on 2 September 2000.
His statement that I`also con¢rmed that this vaccine used in the Le¨opoldville trial had been prepared in a laboratory outside Brussels not re-iced' is [incorrect] . What I con¢rmed was that it was not made in Brussels; this does not imply that I know that it was made elsewhere in Belgium (Gelfand 2000 , his emp hasis).
The passage in Hooper's letter which Gelfand decries is given below.
My motivation for writing this book about p olio vaccination is to provide an accurate account of an esp ecially fascinating p eriod in the history of medicineöfrom the p erspective of the nineties, when the global eradication of polio is at long last a realizable goal. The history of the vaccination campaign in Africa is p articularly intriguing, in that (with the exception of the excellent series of articles about Le¨op oldville campaign), so little has appeared about it either in the literature, or in the several books which have been written on the subject (Hoop er 1996).
As mentioned in the companion paper (Plotkin, this issue), CHAT vaccine was prepared at RIT, but only in 1959, after HIV had infected humans. Only macaque cells were employed, as con¢rmed by Mr P. Gerardy (2001), who was responsible for removal of the monkey kidneys from the time RITopened in 1957.
EVOLUTION OF SIMIAN IMMUNODEFICIENCY VIRUS IN CHIMPANZEES
During The Royal Society meeting several groups presented genetic modelling data that suggested a time for the beginning of HIV-1 evolution of about 1930. Hooper's counterproposal was that SIVcpz evolved in chimpanzees into the many clades of HIV-1, either in a single elderly infected chimp or in multiple chimpanzees, each conveniently carrying a di¡erent clade of the virus. The latter idea appears improbable, as discussed by Sharp at the conference (Sharp et al., this issue) . The former idea, however, seemed to us to be testable by examining the evolution of HIV-1 in experimentally infected chimpanzees.
Patricia Fultz of the University of Alabama, who has studied chimpanzee HIV-1 infections over many years, responded to our inquiry with the following letter.
Relative to the chimp anzees infected with HIV-1, the data at hand that are published are as follows. For two chimpanzees infected for 9 and 10 years with LAI, the pairwise di¡erences in the C2-V5 region of Env range from 2.46 to 3.36 and 0.85 to 1.88, resp ectively. The animal infected 9 yrs when the data were obtained has now been infected for 412 years.
The most diversity that has been documented is from the chimpanzee that was infected with both LAI and SF2 that died of AIDS. The extent of diversity from LAI ranged from 11.9 to 13.2 and from SF2, 16.9 to 19.5. However, multiple recombination events between the two strains which obscure the strain-speci¢c evolution were identi¢ed (Fultz 2000) .
As the variation reported by Fultz did not change the clade of the virus, it appears that the evolutionary rate in HIV-1 infected chimps is insu¤cient to produce multiple clades within a lifetime. Moreover, in the previous article (Plotkin, this issue), we showed that almost all the chimpanzees at Lindi were young animals.
ADDITIONAL PCR TESTS
After The Royal Society Discussion Meeting, it came to our attention that Margareta Bottiger had sent samples of lot 10A-11 received originally from Koprowski to the laboratory of the National Institute of Biological Standards and Control in the United Kingdom. Recently, Neil Almond of that laboratory submitted the samples to PCR tests for simian immunode¢ciency virus or human immunode¢ciency virus and for cell substrate. His results were negative for the former and positive for macaque cell DNA (Berry et al. 2001) . Thus, these additional results con¢rm those reported at the conference by C. Basilico (Blancou et al. 2001; Poinar et al. 2001) , to the e¡ect that the vaccine lots used in the Congo and elsewhere were free of retroviruses and were made in macaque cells.
AFRICAN WITNESSES TO EVENTS AT CAMP LINDI
Hooper has recounted interviews with former African workers at Camp Lindi, but he seldom gives full names so that those individuals can be identi¢ed. His main testimony seems to have been collected from someone named Antoine. We asked D. 
SUMMARY
We have made a strenuous e¡ort to examine the new allegations, particularly the two`smoking guns', but at the end of the investigation there was no gun (the chimpanzees), no bullet (the virus), no shooter (a manufacturer of the vaccine in chimpanzee cells), and no motive to use chimp cells or to hide the fact. The only smoke appeared to be that created by Hooper. The testimony of Bugyaki does not in fact allow the interpretation given to it by Hooper, and the idea that chimpanzee kidneys were extracted at Bujumbura and sent to two veterinary institutes for polio vaccine manufacture has been contradicted both at the supposed source of the animals and at the supposed sites of production.
The results of the extensive investigations summarized here are also worrying because they reveal a modus operandi of Hooper inconsistent with objectivity. Language barrier also may have played a role in his interviews of Africans.
The successive allegations made in The river and at The Royal Society meeting have been clearly and de¢nitively refuted by the available evidence. One can anticipate that additional journalistic accusations will appear in the future, but doubtless those will also prove to be farragos. 
